REGISTERED NUMBER: 05741188 (England and Wales)

THIAZENE LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

Dr J A Durrant

SECRETARY:

Mrs C M Millar

REGISTERED OFFICE:

Sterling House

Fulbourne Road

Walthamstow

London

E17 4EE

REGISTERED NUMBER:

05741188 (England and Wales)

ACCOUNTANTS:

Christiansons Ltd

Chartered Certified Accountants

Sterling House

Fulbourne Road

Walthamstow

London

E17 4EE

FIXED ASSETS

Property, plant and equipment

4

140

140

Investment property

5

500,000

398,576

500,140

398,716

CURRENT ASSETS

Debtors

6

171

-

Cash at bank

71,019

66,743

71,190

66,743

CREDITORS

Amounts falling due within one year

7

8,039

7,700

NET CURRENT ASSETS

63,151

59,043

TOTAL ASSETS LESS CURRENT LIABILITIES

563,291

457,759

PROVISIONS FOR LIABILITIES

11,326

-

NET ASSETS

551,965

457,759

CAPITAL AND RESERVES

Called up share capital

100

100

Fair value reserve

8

90,098

-

Retained earnings

461,767

457,659

SHAREHOLDERS' FUNDS

551,965

457,759

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 12 January 2026 and were signed by:

Dr J A Durrant - Director

1.	STATUTORY INFORMATION

Thiazene Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover represents net rents receivable and services provided, excluding value added tax. Turnover is recognised when rent becomes due under the lease agreement.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on reducing balance

Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4.	PROPERTY, PLANT AND EQUIPMENT

Plant and

machinery

etc

£

COST

At 1 May 2024

and 30 April 2025

3,789

DEPRECIATION

At 1 May 2024

and 30 April 2025

3,649

NET BOOK VALUE

At 30 April 2025

140

At 30 April 2024

140

5.	INVESTMENT PROPERTY

Total

£

FAIR VALUE

At 1 May 2024

398,576

Revaluations

101,424

At 30 April 2025

500,000

NET BOOK VALUE

At 30 April 2025

500,000

At 30 April 2024

398,576

Fair value at 30 April 2025 is represented by:

£

Valuation in 2025

500,000

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.4.25

30.4.24

£

£

Other debtors

171

-

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.4.25

30.4.24

£

£

Taxation and social security

339

-

Other creditors

7,700

7,700

8,039

7,700

8.

RESERVES

Fair

value

reserve

£

Fair value movement

90,098

At 30 April 2025

90,098

9.	ULTIMATE CONTROLLING PARTY

There is no overall control of the company by any one person.